Evidence map›Paper›PMID 39945843›Full record

ArticleImmunogenetics2025

Primary regulatory T cell activator FOXP3 is present across Amphibia.

Rebecca A Clemons, Chase H Smith, Kelly R Zamudio

Abstract read
PubMed Publisher
In one paragraph

Article in Immunogenetics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Rebecca A ClemonsDepartment of Integrative Biology, The University of Texas at Austin, Austin, TX, USA. rclemons@utexas.edu.ORCID http://orcid.org/0009-0007-9320-5898
Chase H SmithDepartment of Integrative Biology, The University of Texas at Austin, Austin, TX, USA.ORCID http://orcid.org/0000-0002-1499-0311
Kelly R ZamudioDepartment of Integrative Biology, The University of Texas at Austin, Austin, TX, USA.ORCID http://orcid.org/0000-0001-5107-6206

Funding

National Science Foundation DEB-2316467
6 · The paper itself

Abstract

The overall structure of the immune system is highly conserved across jawed vertebrates, but characterization and description of the immune system is heavily biased toward mammals. One arm of the vertebrate immune system, the adaptive immune system, mounts pathogen-specific responses that tend to be robust and effective at clearing pathogens. This system requires selection against self-recognition and modulation of the immune response. One of the mechanisms of immune modulation is the presence of regulatory T cells that suppress other effector immune cells. Regulatory T cells and their primary activator forkhead box protein P3 (FOXP3) have been well characterized in mammalian models but unexplored in most other vertebrate taxa. Amphibians are a good focal group for the characterization of FOXP3 due to their phylogenetic position on the vertebrate tree of life, and their susceptibility to emerging pathogens. In this study, we mined available transcriptomic and genomic data to confirm the presence of FOXP3 across the amphibian tree of life. We find that FOXP3 is present in all major clades of amphibians. We also test whether selection on FOXP3 shows signatures of intensification among the three main clades of amphibians, which may reflect shifts in the stringency of natural selection on this gene. Our findings provide insights into the evolutionary history of the vertebrate immune system and confirm the conservation of vertebrate immune genes within amphibians.

Indexed as

AmphibiansForkhead Transcription FactorsT-Lymphocytes, RegulatoryAnimalsEvolution, MolecularPhylogenySelection, GeneticTranscriptomeForkhead Transcription FactorsAdaptive immunityAmphibianImmune conservationImmune suppressionSelectionTranscription factor

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.